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Abstract
Despite the increased awareness of differences in the inflammatory response between men and women, only limited
research has focused on the biological factors underlying these sex differences. The cholesterol derivative 27-hydroxy-
cholesterol (27HC) has been shown to have opposite inflammatory effects in independent experiments using mouse
models of atherosclerosis and non-alcoholic steatohepatitis (NASH), pathologies characterized by cholesterol-induced
inflammation. As the sex of mice in these in vivomodels differed, we hypothesized that 27HC exerts opposite inflamma-
tory effects in males compared to females. To explore whether the sex-opposed inflammatory effects of 27HC translated
to humans, plasma 27HC levels were measured and correlated with hepatic inflammatory parameters in obese individ-
uals. To investigate whether 27HC exerts sex-opposed effects on inflammation, we injected 27HC into female and male
Niemann–Pick disease type C1mice (Npc1nih) that were used as an extrememodel of cholesterol-induced inflammation.
Finally, the involvement of estrogen signaling in this mechanism was studied in bone marrow-derived macrophages
(BMDMs) that were treated with 27HC and 17β-estradiol (E2). Plasma 27HC levels showed opposite correlations with
hepatic inflammatory indicators between female and male obese individuals. Likewise, hepatic 27HC levels oppositely
correlated between female and male Npc1nihmice. Twenty-seven hydroxycholesterol injections reduced hepatic inflam-
mation in female Npc1nih mice in contrast to male Npc1nih mice, which showed increased hepatic inflammation after
27HC injections. Furthermore, 27HC administration also oppositely affected inflammation in female and male BMDMs
cultured in E2-enrichedmedium. Remarkably, female BMDMs showed higher ERα expression compared to male BMDMs.
Our findings identify that the sex-opposed inflammatory effects of 27HC are E2-dependent and are potentially related
to differences in ERα expression between females and males. Hence, the individual’s sex needs to be taken into account
when 27HC is employed as a therapeutic tool as well as in macrophage estrogen research in general.
© 2020 The Authors. The Journal of Pathology published by JohnWiley & Sons Ltd on behalf of Pathological Society of Great Britain and
Ireland.
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Introduction
An increasing amount of evidence has pointed towards
sex differences influencing physiological processes,
including inflammatory responses [1–5]. In spite of these
physiological differences between men and women,
only limited research has focused on the biological fac-
tors underlying these differences. As gender-based pre-
vention and therapy, as opposed to the ‘one-size-fits
all’ approach, is expected to benefit both male and
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female patients [5], it is essential to improve our under-
standing on these underlying biological factors involved
with sex differences.
Metabolically-induced inflammatory responses (referred
to as metabolic inflammation or metaflammation) such as
cholesterol-induced activation of macrophages [6,7] have
been generally accepted as a cause for the chronic low-
grade inflammatory state observed in obese patients [8].
Metaflammation is also responsible for the steep increase
in the amount of obese individuals suffering from hepatic
inflammation [9], identifying the liver as one of the most
sensitive organs for cholesterol- and lipid-induced meta-
flammation [10]. Relevantly, cholesterol-derived lipids
known as oxysterols have been linked to obesity-associated
inflammatory conditions [11,12]. The most abundant
oxysterol in the human body is 27-hydroxycholesterol
(27HC) [13], which is generated via enzymatic oxidation
of cholesterol by sterol 27-hydroxylase (CYP27A1)
[14]. Due to its cholesterol-expelling effects [15],
27HC has been investigated as a therapeutic agent in ath-
erosclerosis and non-alcoholic steatohepatitis (NASH),
pathologies characterized by cholesterol-inducedmacro-
phage activation leading to inflammation [7,16–19].
Whereas hematopoietic overexpression of Cyp27a1
[20] and subcutaneous administration of 27HC in female
hyperlipidemic mice [21] resulted in reduced hepatic
inflammation, subcutaneous injections of 27HC in a
comparable male hyperlipidemic mouse model para-
doxically elevated atherosclerosis via increasing pro-
inflammatory processes [22]. These results suggest that
sex differences may underlie the opposite effects of
27HC on cholesterol-induced inflammation.
Based on these findings, we hypothesized that under
cholesterol-induced inflammatory conditions, 27HC exerts
sex-opposed inflammatory effects. Firstly, we found in a
cohort of obese individuals that higher plasma 27HC levels
in females corresponded with lower hepatic inflammatory
indicators, while the opposite was observed in males.
Similar sex-opposed inflammatory effects of 27HC were
observed in Niemann–Pick nih mice (Npc1nih), here used
as an extrememodelmimicking cholesterol-induced inflam-
mation [23]. Finally, in vitro experiments with murine bone
marrow-derived macrophages (BMDMs) provided
evidence that the sex-opposed inflammatory effect of
27HC is E2-dependent and is potentially related to
differences in ERα expression between females and
males. Altogether, these data demonstrate for the first
time the sex-opposed effects of 27HC on inflammation.
Hence, the individual’s sex needs to be taken into
account when 27HC is employed as a therapeutic tool.
Materials and methods
Human subjects
The study was carried out in accordance with the
approved guidelines by the Medical Ethical Committees
of both the Maastricht University Medical Centre and
the Atrium Medical Centre Parkstad and conducted in
accordance with the revised version of the Declaration
of Helsinki (October 2008, Seoul) [24]. Written
informed consent was obtained from all the subjects.
The Maastricht cohort included obese adult individ-
uals (34; 21 females and 13 males) undergoing bariatric
surgery at theMaastricht UniversityMedical Center or at
the AtriumMedical Center Parkstad, Heerlen, The Neth-
erlands. Population characteristics are represented in
supplementary material, Table S1A. NASH was deter-
mined by evaluation of liver biopsies based on Brunt’s
criteria by a trained pathologist. Exclusion criteria, the
procedure of obtaining liver biopsies, and blood sam-
pling of this cohort have been previously described
[25,26]. Determination of plasma 27HC levels was per-
formed as described previously [21].
Mice, diet, and treatment
Experiments were performed according to the Dutch
regulation and approved by the Committee for Animal
Welfare of Maastricht University. Npc1nih mice were
housed under standard conditions and were given free
access to food and water. Npc1nih mice (a kind gift from
Professor Dr Lieberman from University of Michigan
Medical School) were derived from heterozygous foun-
ders (C57BL/6-Npc1nih). In the first in vivo experiment,
7-week-old female (n = 4) and male (n = 4) Npc1nih
mice were given a normal chow diet and sacrificed. In
the second in vivo experiment, 2-week-old female
(n = 5 per group) and male (n = 5 per group) Npc1nih
mice were injected daily with 27-hydroxycholesterol
(27HC; 40 mg/kg) or vehicle (2-hydroxypropyl-
β-cyclodextrin 18%) for 21 weeks and given a normal
chow diet. Tissue specimens were isolated and snap-
frozen in liquid nitrogen and stored at −80 C or fixed
in 4% formaldehyde/PBS. The collection of blood and
hepatic and bile oxysterols was carried out as described
previously [19,27,28]. Product information is provided
in supplementary material, Table S1.
RNA isolation/cDNA synthesis/RT-qPCR
Total RNA was isolated from mouse liver tissues or cul-
tured bone marrow-derived macrophages (BMDMs).
For liver tissues, homogenization was achieved by add-
ing 1.0 ml of glass beads and 1.0 ml of Tri Reagent
(Sigma Aldrich, St Louis, MO, USA) to the frozen liver
tissues in a closed tube for 30 s at 4800 rpm. For
BMDMs, 350 μl of Tri Reagent was added to the well,
after which BMDMs were transferred to a tube. After
addition of chloroform (200 μl for liver tissues and
100 μl for BMDMs) and centrifugation, the aqueous
phase was transferred to a fresh tube. Isopropanol
(0.5 ml) was added and following another centrifugation
step, RNA was pelleted and then washed by adding
1.0 ml of 70% ethanol. After a further centrifugation
step, the supernatant was removed and the pellet was dis-
solved in an appropriate volume of DEPC sterile H2O.
All materials used were RNase-free and samples were
placed on ice during the procedures. Afterwards, the
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concentration and quality of RNA were determined
using a NanoDrop ND-1000 spectrophotometer.
Total RNA (500 ng for liver and 300 ng for BMDMs)
was reverse-transcribed into complementary DNA
(cDNA) using an iScript cDNA synthesis kit according
to the manufacturer’s instructions. Changes in the
expression of the indicated genes were determined by
qPCR using 10 ng of cDNA on Bio-Rad MyIQ with
IQ5 v2.1 software (ABI 7900; Applied Biosystems, Fos-
ter City, CA, USA) using IQ SensiMix SYBR master
mix with fluorescein (Bioline, London, UK). Cyclophi-
lin A (PpiA), ribosomal protein S12 (Rps12), and Actb
were used as reference genes to standardize for the
amount of cDNA. By using the default settings in primer
Express version 2.0 (Applied Biosystems), primer sets
for the selected genes were developed and are available
in supplementary material, Table S2. RT-qPCR data
were analyzed according to the relative standard curve
method.
Immunohistochemistry
Frozen liver sections (7 μm) were fixed in acetone and
subsequently endogenous peroxidase was blocked by
incubation with a 1:400 dilution of 30% H2O2 for
5 min. Prior to incubation with the first antibody, slides
were incubated with 4% new-born calf serum (Bodinco,
Alkmaar, The Netherlands)/1× PBS + 1:5 Avidin D
Block solution (Vector Laboratories, Burlingame, CA,
USA). Primary antibodies were used to detect infiltrated
macrophages and neutrophils (Mac1, 101207, cloneM1/
70; Biolegend, Amsterdam, The Netherlands). For
NIMP (HM1039PE-100, clone NIMP-R14; Hycult Bio-
tech, Uden, The Netherlands) staining, no amplification
step was needed and an anti-rat:peroxidase conjugate
was used for the second layer. For the incubation step
with the first antibody, we used 4% FCS/1× PBS + 1st
antibody (Mac1, 1:500; NIMP, 1:100) + 1:5 Biotin
Block solution (ABC kit) (Vector Laboratories). Incuba-
tion with the second antibody (1:300 anti-rat:biotin con-
jugate or 1:100 anti-rat:peroxidase conjugate) was in 4%
FCS/2% normal mouse serum (Invitrogen, Carlsbad,
CA, USA)/1× PBS. After this, the slides were washed
and incubated in 1× PBS + 1:50 Biotin solution (ABC
kit) (Vector Laboratories). An AEC kit (2% buffer/3%
AEC/2%H2O2; Bio-connect, Huissen, TheNetherlands)
in demineralized water was used to develop color and
hematoxylin (Klinipath, Olen, Belgium) for nuclear
counterstaining. Sections were mounted under glass
using Faramount aqueous mounting medium (Agilent
Technologies, Santa Clara, CA, USA).
Sections of paraffin-embedded liver, cut at 4 μm, were
stained with hematoxylin and eosin (H&E) after dewax-
ing in xylene and rehydrating with 90%, 70%, and 50%
ethanol. Sections were mounted using Entellan (Merck,
Branchberg, NJ, USA). Pictures were taken using a
Nikon DMX1200 digital camera and ACT-1 v2.63 soft-
ware (Nikon, Tokyo, Japan). Immune cells were counted
in six microscopic views (original magnification 200×)
and were recorded as cells per square millimeter.
Cell culture
BMDMs were isolated from the tibiae and femurs of
male or female Npc1nih and Wt C57BL/6 mice. Cells
were cultured for 8 days in RPMI-1640 supplemented
with 10% heat-inactivated new-born calf serum, penicil-
lin (100 U/ml), streptomycin (100 μg/ml), and L-gluta-
mine (2 mM), supplemented with 20% L929-
conditioned medium (LCM) to generate BMDMs. After
attachment, BMDMs were seeded at 350 000 cells per
well in 24-well plates. A complete overview of the
experiment is depicted in supplementary material,
Figure S1. At the end of the experiment, medium was
collected and cells were lysed for mRNA expression or
protein analysis. All in vitro data represent at least
n = 3 (triplicates) for each experimental group.
Nitric oxide measurement
Levels of nitric oxide (NO) were measured in medium
using the Griess [0.1% naphthylethylenediamine dihy-
drochloride (Sigma-Aldrich, St Louis, MO, USA); 1%
sulfanilamide (Sigma-Aldrich); 2.5% phosphoric acid
(Merck)] test protocol. A standard curve was made using
dilutions of NaNO2 in E2 (Sigma-Aldrich) medium: 10,
8.75, 7.5, 6.25, 5, and 3.75 μl (E2 medium blank), and
50 μl of standard dilution and 45 μl of samples + 5 μl
of 50 μM NaNO2 were pipetted into the wells of a
96-well plate. Griess agent (50 μl) was added andAbsor-
bance was measured at 545 nm.
Tumor necrosis factor alpha (TNFα), interleukin 10
(IL-10), estrogen receptor alpha (ERα) and estrogen
receptor beta (ERβ), liver X receptor beta (LXRβ)
enzyme linked immunosorbent assays (ELISA)
ELISA for mouse TNFα (17644800; Invitrogen) and IL-
10 (218449-002; Invitrogen) were performed on culture
medium of bone marrow-derived macrophages according
to the manufacturer’s instructions [sensitivity: 8 pg/ml
(TNFα), 23 pg/ml (IL-10); specificity: cross-contamination
from other species possible]. Protein levels of ERα
(E-EL-M0476; Elabscience, Wuhan, PR China) and
ERβ (E-EL-M0490; Elabscience) in cell lysates of bone
marrow-derived macrophages were measured by ELISA
according to the manufacturer’s instructions (ERα sensi-
tivity: 0.19 ng/ml and ERβ sensitivity: 0.19 ng/ml). No
significant cross-reactivity or interference between ERα
and ERβ was observed. LXRβ (MOEB0190; Medical
Supply Company, Dublin, Ireland) was measured in cell
lysates of Wt bone marrow-derived macrophages
according to the manufacturer’s instructions.
Statistical analysis
The differences between the experimental groups were
analyzed with two-way ANOVA followed by Tukey’s
post hoc test using the IBM® SPSS Statistics program
(Version 22.0.0.) or GraphPad Prism (Version 6.01;
GraphPad Inc, San Diego, CA, USA). GraphPad Prism
(Version 6.01) was used to calculate and display results
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as mean ± SEM (*p ≤ 0.05; **p ≤ 0.01). Pearson corre-
lation coefficients (r) and respective P values were cal-
culated to assess the statistical significance of
correlations.
Results
Plasma 27-hydroxycholesterol levels are oppositely
associated with hepatic inflammatory indicators
between female and male obese individuals
To explore whether sex is associated with the inflamma-
tory effect of 27HC, plasma 27HC levels were measured
in an obese population and correlated with different
hepatic inflammatory indicators. Clinical characteristics
of the population are presented in supplementary mate-
rial, Table S3. In the ‘Maastricht cohort’ (n = 43),
plasma 27HC levels were significantly lower in female
NASH individuals (categorized by criteria of Brunt) than
in no-NASH obese females (Figure 1A and supplemen-
tary material, Figure S2A, left panel). Conversely, in
male NASH individuals, plasma 27HC levels were
increased compared with no-NASH obese males (Fig-
ure 1A and supplementary material, Figure S2A, right
panel). Similarly, when plasma 27HC levels were specif-
ically compared with hepatic lobular inflammation in the
same obese population, significantly lower plasma
27HC levels were observed in obese females suffering
from hepatic lobular inflammation (Figure 1B and sup-
plementary material, Figure S2B, left panel), while an
increasing trend was found for plasma 27HC levels in
obese males (Figure 1B and supplementary material,
Figure S2B, right panel). These results show that plasma
27HC levels oppositely correlate with hepatic inflamma-
tory indicators in female and male obese individuals,
confirming the sex-opposed inflammatory association
with 27HC that was previously observed in hyperlipi-
demic models [20–22].
Hepatic 27HC levels oppositely correlate with
hepatic inflammation between female and male
Npc1nih mice
To validate the sex-opposed inflammatory effect of
27HC in vivo, hepatic inflammation and hepatic 27HC
levels were assessed in 7-week-old female andmale Nie-
mann–Pick type C1 disease (NPC1) mice (Npc1nih
mice). Cryosections of liver were stained for the inflam-
matory markers Mac1 (infiltrated macrophages and neu-
trophils) and NIMP (neutrophils), and subsequently
correlated with hepatic 27HC levels. Hepatic 27HC
levels inversely correlated with both hepatic infiltrated
macrophages and neutrophils (r = −0.8605; Table 1
and supplementary material, Figure S3A,B) and hepatic
neutrophils (r = −0.9669; Table 1 and supplementary
material, Figure S3A,B) in female Npc1nih mice. In con-
trast, male Npc1nih mice showed a positive correlation
between hepatic 27HC levels and hepatic infiltrated
macrophages and neutrophils (r = 0.9595; Table 1 and
supplementary material, Figure S3A,B) and hepatic neu-
trophils (r = 0.88; Table 1 and supplementary material,
Figure S3A,B). Furthermore, no other significant differ-
ences were observed between female and male Npc1nih
mice (supplementary material, Table S4). As such, our
data show that hepatic 27HC levels have sex-opposed
hepatic inflammatory associations, validating Npc1nih
mice as a model to investigate the sex-opposed inflam-
matory effects of 27HC.
Administration of 27HC in Npc1nih mice results in
opposite hepatic inflammatory responses between
sexes
To determine whether 27HC induces the sex-opposed
effects on hepatic inflammation, female and male
Npc1nih mice were given daily subcutaneous injections
of 27HC or vehicle for 21 weeks. Hepatic and bile
27HC levels increased in both female and male Npc1nih
mice upon 27HC administration, confirming successful
administration of 27HC (supplementary material, Fig-
ure S4). In line with our hypothesis, administration of
27HC in femaleNpc1nihmice reduced hepatic inflamma-
tion, as observed by H&E staining (Figure 2A and sup-
plementary material, Figure S5) and decreased
numbers of infiltrated macrophages and neutrophils
(Figure 2B) in comparison to non-treated animals. In
contrast, administration of 27HC in male Npc1nih mice
resulted in a pro-inflammatory response compared with
vehicle-treated male Npc1nih mice (Figure 2A,B). These
histological observations were further substantiated by
hepatic gene expression levels for the inflammatory
markers tumor necrosis factor alpha (Tnf), chemokine
(C-X-Cmotif) ligand 2 (Cxcl2), cluster of differentiation
68 (Cd68), integrin alpha M (Itgam), intercellular adhe-
sion molecule 1 (Icam1), and interleukin 18 (Il18) (Fig-
ure 2C), showing tendencies towards decreased or
increased inflammation in female or male Npc1nih mice,
respectively. Moreover, the interaction term provided by
two-way ANOVA analysis was significant among all
hepatic inflammatory analyses (Table 2), indicating that
the hepatic inflammatory effect of 27HC is influenced
by sex.
Only in the presence of E2 are the inflammatory
effects of 27HC sex-dependent in murine bone
marrow-derived macrophages
As 27HC has been identified as a selective estrogen
receptor modulator (SERM) [14] and estrogen is known
to influence inflammatory processes [29], we first
assessed the effect of 27HC in murine BMDMs cultured
in E2-depleted and -enriched conditions by measuring
nitric oxide (NO), a key mediator of inflammation. Vehi-
cle-treated BMDMs cultured in E2-enriched medium
showed reduced production of NO compared with vehi-
cle-treated BMDMs cultured in E2-depleted (‘Control’)
medium, confirming the modulatory role of E2 in NO
production (Figure 3A,B). Strikingly, treating BMDMs
cultured in E2-enriched medium with 27HC resulted in
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increased NO production, which was opposite in
BMDMs cultured in E2-depleted medium, where treat-
ment with 27HC reduced NO production (Figure 3A,
B). These results confirm that 27HC modifies the estro-
gen-mediated inhibition of NO production, and therefore
inflammation.
Next, we investigated whether the sex-opposed
inflammatory effects of 27HC are E2-dependent. For
this purpose, Wt BMDMs derived from female or male
mice were cultured in E2-depleted or E2-enriched
medium and treated with 27HC (1.0 or 1.5 μM) or vehicle
for 24 h. Under E2-depleted conditions, 27HC treatment
reduced TNFα levels in female- and male-derived
BMDMs (Figure 3B, left panel). In contrast, under E2-
enriched conditions, 27HC treatment only reduced
TNFα levels in females, but not in males (Figure 3B,
right panel). Moreover, upon incubation with 1.5 μM
27HC, TNFα levels were significantly increased in
males (Figure 3B, right panel). These observations were
confirmed at gene expression level, showing similar
trends for Tnf, Icam1, and Il1b expression (supplemen-
tary material, Figure S6A). Sex, however, did not influ-
ence IL-10 levels after 27HC treatment (supplementary
material, Figure S6B). Additionally, to confirm whether
these inflammatory effects were more pronounced in an
extreme model of cholesterol-induced inflammation,
female- and male-derived Npc1nih BMDMs were
exposed to conditions similar to those of Wt BMDMs.
As expected, only under E2-enriched conditions did
the sex-opposed inflammatory effects of 27HC become
apparent, demonstrating reduced TNFα levels in females
and increased TNFα levels in males (Figure 3C and
Table 3). This observation was also further confirmed
at gene expression level for Tnf and Icam1 (Figure 3D
Figure 1. Relative plasma 27HC levels in female and male obese individuals in relation to hepatic inflammatory indicators. (A) Plasma 27HC
levels in obese women and men categorized as ‘NASH’ or ‘Normal’ based on assessment of liver biopsies according to the criteria of Brunt. (B)
Plasma 27HC levels in female and male obese individuals categorized according to the presence of hepatic lobular inflammation. *p ≤ 0.05
compared with obese individuals categorized as ‘Normal’ (A) or obese individuals without hepatic lobular inflammation (B) by use of two-
tailed unpaired t-test. Panels A and B show n = 34 (21 female and 13 male individuals). All error bars are SEM.
Table 1. Correlation analysis between hepatic 27-hydroxycholesterol levels and hepatic inflammation in 7-week-old female and male
Npc1nih mice.
Hepatic 27HC/Chol levels (ng/mg)
Pearson r R2 P value
Female
Hepatic infiltrated macrophages and neutrophils (No of positive cells/mm2) −0.8605 0.7404 0.13
Hepatic neutrophils (No of positive cells/mm2) −0.9669 0.9349 0.03*
Male
Hepatic infiltrated macrophages and neutrophils (No of positive cells/mm2) 0.9595 0.9206 0.04*
Hepatic neutrophils (No of positive cells/mm2) 0.8861 0.7851 0.11
*p ≤ 0.05 by means of Pearson correlation. n = 4 per experimental group.
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and Table 3). Together, these findings indicate that the
sex-opposed inflammatory effects of 27HC are E2-
dependent and imply that the downstream E2 signaling
is different in females and males.
Female BMDMs show higher ERα expression
compared with male BMDMs
To provide insight into the underlying mechanism that
explains the E2-driven opposite inflammatory effect of
27HC on females and males, we determined protein
levels of estrogen receptors alpha and beta (ERα and
ERβ) and liver X receptor beta (LXRβ) in untreated Wt
BMDMs derived from female and male mice (Fig-
ure 4A,B). While ERβ and LXRβ levels were similar
between females and males, ERα levels showed almost
Figure 2. Hepatic inflammatory parameters of female and male Npc1nihmice after 27HC administration. (A, B) Quantification of hematoxylin
and eosin (H&E) staining and Mac1 immunostaining of livers from female and male Npc1nih mice treated with or without 27HC. (C) Hepatic
gene expression analysis of Tnf, Cxcl2, Cd68, Itgam, Icam1, and Il18 of female and male Npc1nihmice treated with or without 27HC. *p ≤ 0.05
and **p ≤ 0.01 by use of two-way ANOVA with Tukey’s post hoc correction. n = 4 or 5 mice per experimental group. All error bars are SEM.
Table 2. Statistics of sex-opposed hepatic inflammatory effects of
27HC in Npc1nih mice.
P value (sex*27HC treatment
interaction term)
Histology











*p ≤ 0.05 and **p ≤ 0.01 by two-way ANOVA. n = 4 or 5 mice per experimental
group.
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three-fold higher protein expression in female compared
with male BMDMs (Figure 4A,B). Moreover, in
females, ERα expression was two-fold higher than ERβ
expression, while in males ERα and ERβ showed almost
equal protein expression (Figure 4A). Considering the
modulating effect of these estrogen receptor subtypes
Figure 3. Inflammatory indicators of female and male-derived Wt bone marrow-derived macrophages cultured in E2-enriched/-depleted
medium treated with 27HC. (A) Nitric oxide (NO) production in female (left panel) and male (right panel) wild-type BMDMs. *p ≤ 0.05 com-
pared with vehicle-treated BMDMs by use of two-way ANOVA with Tukey’s post hoc correction. #p ≤ 0.05 compared with E2-depleted (‘Con-
trol’) BMDMs treated with vehicle. (B) TNFα protein levels in female and maleWt BMDMs. *p ≤ 0.05 and **p ≤ 0.01 compared with vehicle-
treated female- or male-derived BMDMs cultured under E2-depleted conditions by use of two-way ANOVA with Tukey’s post hoc correction
(left panel). *p ≤ 0.05 is compared with vehicle-treated female- or male-derived BMDMs cultured under E2-enriched conditions (right panel).
Results are shown as the average of three independent experiments. All error bars are SEM. (C) TNFα protein levels in female and maleNpc1nih
BMDMs. *p ≤ 0.05 and **p ≤ 0.01 compared with vehicle-treated female- or male-derived BMDMs cultured under E2-enriched conditions by
use of two-way ANOVA with Tukey’s post hoc correction (right panel). Results are shown as the average of one independent experiment. All
error bars are SEM. (D) Gene expression analysis of Tnf and Icam1 in female and maleNpc1nih BMDMs. *p ≤ 0.05 compared with vehicle-trea-
ted female- or male-derived BMDMs cultured under E2-enriched conditions by use of two-way ANOVA with Tukey’s post hoc correction.
#p ≤ 0.05 and ##p ≤ 0.01 compared with vehicle-treated female BMDMs by use of two-way ANOVA with Tukey’s post hoc correction. Results
are shown as the average of one experiment with three technical replicates. All error bars are SEM.
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on inflammatory responses, our findings suggest that the
sex-opposed inflammatory effect of 27HC might be
related to different ERα expression between female and
male macrophages.
Discussion
Despite the increased awareness of differences in the
inflammatory response between men and women, only
limited research has focused on the biological factors
underlying these sex-opposed effects. Here, we identify
27HC as a biological factor exerting sex-opposed effects
on inflammation and show that these sex-opposed effects
are mediated via differences in estrogen signaling. Hence,
the individual’s sex needs to be taken into account when
27HC is employed as a therapeutic tool as well as in mac-
rophage estrogen research in general.
An increasing amount of research is pointing towards
the therapeutic potential of bile acids (and their precur-
sors) to modulate the inflammatory response in meta-
bolic diseases such as cardiovascular diseases [30],
diabetes [31], NASH [32], and even in pulmonary dis-
eases [33,34]. With regard to this evolving trend, we
demonstrate in the current study that sex plays a key role
in the inflammatory effect of the bile acid precursor
27HC, which likely explains the previous contradictive
results in atherosclerosis [22] and NASH [20,21]. Our
findings suggest that bile acids and their precursors
potentially have opposite inflammatory effects in
females and males, warranting caution on the use of bile
acids as a therapeutic tool in the clinic without conduct-
ing sex-specific clinical trials. Indeed, in the past, sex
bias has been identified in the search for new therapeutic
drugs in both preclinical animal studies and clinical
human studies that included more male than female indi-
viduals [35,36]. In the cardiovascular field, this phenom-
enon has led to differences in the clinical outcome of
males versus females in relation to key drugs such as
beta-blockers, angiotensin-converting enzyme inhibi-
tors, diuretics, and anti-arrhythmics [36]. As, to our
knowledge, this is the first study to describe sex-related
differences in the context of bile acids, future research
is necessary to validate our observation. So far, gender-
specific health care is only present in very limited quan-
tities and epidemiological research proving sex differ-
ences [37,38] are only recently finding their way to
larger scientific audiences, which is exemplified by
funding agencies specifically endorsing research investi-
gating female/male differences [39,40]. Our findings
therefore add fuel to the increasing concept of men and
women as two different entities whose health and dis-
ease condition should be approached from a different
perspective.
While a chronic low-grade inflammatory state is as a
key factor contributing to the prevalence of obesity-
associated disorders [6,7,41], only recently has it become
clear that there are differences between the sexes concern-
ing this obesity-associated inflammatory response.
Plasma adiponectin concentrations were demonstrated to
decrease more dramatically in obese male than in female
patients [42], providing evidence for a more detrimental
inflammatory state in obese male compared with obese
female patients. Additionally, whereas male high-fat
diet-induced obese mice showed profound adipose tissue
macrophage accumulation [43] and infiltration [44],
female obese mice were protected from this adipose tissue
inflammatory response [43,44]. Singer et al suggested
that the absence of adipose tissue inflammation in female
high-fat diet-induced obese mice is likely due to the
formation of CD11c− (M2-like) macrophages, while
matchedmale mice show expansion of CD11c+ (M1-like)
macrophages in adipose tissue [45]. These findings
suggest a key role for macrophages in mediating opposite
inflammatory responses between females and males. In
Table 3. Statistics of sex-opposed inflammatory effects of 27HC in
Npc1nih BMDMs.











*p ≤ 0.05 and **p ≤ 0.01 by two-way ANOVA. n = 3 per experimental group.
Figure 4. Protein expression of ERα, ERβ, and LXRβ in female and
male Wt bone marrow-derived macrophages. (A) ERα and ERβ and
(B) LXRβ expression in female and male BMDMs. **p ≤ 0.01 com-
pared with female ERβ expression and ##p ≤ 0.01 compared with
female ERα expression by use of two-way ANOVA with Tukey’s post
hoc correction. Results are shown as the average of three indepen-
dent experiments. All error bars are SEM.
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line with this view, we observed here that the cholesterol
derivative 27HC exerts anti-inflammatory effects in the
livers of females and pro-inflammatory effects in the
livers of males and that we could replicate these findings
in primary macrophages as well as validate them in a
cohort of obese individuals. The sex-dependent inflam-
matory influence of 27HC on macrophages has been
confirmed in other experiments showing that 27HC exerts
pro-inflammatory effects on male-derived macrophages
[46], whereas anti-inflammatory effects are observed in
female-derived macrophages [20]. Therefore, future
studies focusing on the inflammatory effect of 27HC in
macrophages have to consider sex as a potential variable
influencing the outcome of their studies.
The observation that the presence of estrogen is essen-
tial to observe the sex-opposed inflammatory effects of
27HC in BMDMs indicates a key role for estrogen in
the 27HC-induced effect on inflammation. This observa-
tion is in line with previous findings of Umetani et al,
who linked 27HC to estrogen by identifying 27HC as
the first endogenous selective estrogen receptor modula-
tor (SERM) [14]. Estrogens are known to dampen,
reduce, and inhibit inflammatory responses by various
mechanisms, including via activation of ER dimers that
repress transcription of, for instance, iNOS [47]. Indeed,
we found that estrogen reduces NO production and,
additionally, that administration of 27HC in the absence
of E2 resulted in a similar decrease in NO production,
suggesting a similar effect of E2 and 27HC on ER
dimers. Simultaneous administration of E2 and 27HC,
on the other hand, causes a conformational change in
ER dimers [47], blocking their repressive effect on tran-
scription and explaining the increased NO production.
These observations therefore confirm that 27HC is a
SERM. Additionally, besides ER dimers, estrogens also
influence inflammation via repressing the transcription
factor NF-κB [29], a master regulator of inflammation
[48]. Indeed, we found that downstream targets of
NF-κB, TNFα, ICAM, and IL-1β, decreased in female-
derived, but not male-derived, BMDMs cultured in
E2-enriched medium that were treated with 27HC. As
production of the inflammatory mediator NO (which is
not NF-κB-mediated) [49] was not differentially
influenced by 27HC among the sexes, our observations
provide evidence that the sex-opposed inflammatory
effect of 27HC is likely related to NF-κB-mediated
mechanisms.
Additionally, our findings further support that the sex-
opposed inflammatory effects of 27HC are at least partly
mediated via differences in downstream estrogen signal-
ing of macrophages. This observation raises the question
of how downstream estrogen signaling in macrophages
is different in females and males. While estrogen exerts
anti-inflammatory effects in both females and males
[50], a potential answer to this exciting question might
be related to sex differences in the distribution of the dif-
ferent ERs, ERα and ERβ. Indeed, while ERβ expression
was similar, we observed a substantial increased
expression of ERα in female compared with male
BMDMs, suggesting that females showmore pronounced
ERα-mediated macrophage responses that underlie the
observed anti-inflammatory effect of 27HC in females.
In line with this observation, ERα expression in macro-
phages has been linked to anti-inflammatory responses
in skin repair [51] and infectious immunity [52]. More-
over, while ERα and ERβ share a high degree of homol-
ogy, their target genes differ substantially, indicating
that the binding of ligands (such as 27HC) to different
ER subtypes impacts the fate of the inflammatory signal-
ing [53]. For these reasons, future research should further
investigate whether differences in the distribution of ERα
and ERβ determine the inflammatory fate of 27HC. The
different ERα expression levels between females and
males also highlight sex as an essential factor to be con-
sidered when investigating macrophage estrogen signal-
ing, irrespective of 27HC levels. As such, for future
research, it is indispensable to determinewhether themac-
rophages under investigation are derived from female or
male sources.
As cholesterol levels increase during obesity in men
and women [54] and 27HC levels are tightly correlated
with cholesterol levels, our findings suggest that
increased cholesterol levels will result in a more detri-
mental inflammatory response in males than in females.
Indeed, previous reports have described that premeno-
pausal women are better protected frommetaflammatory
insults compared with male individuals [55]. Addition-
ally, the premenopausal inflammatory resilience in
women reverses after menopause [56], suggesting that
estrogen plays a key role in mediating the metaflamma-
tory response. Nevertheless, estrogen administration in
postmenopausal women resulted in a paradoxical
increased risk of inflammation and cardiovascular dis-
ease [57,58], suggesting that other biological factors
might be involved in the inflammatory response in
females. Considering our findings that 27HC is affecting
inflammation via perturbing estrogen signaling and the
previous observation of increased LDL cholesterol
(and concomitantly 27HC) levels after menopause
[59], an interesting line for future research would be to
explore whether the inflammatory effect of 27HC is dif-
ferent in pre- versus post-menopausal women.
Overall, we have shown here that 27HC exerts sex-
opposed effects on cholesterol-induced inflammatory
responses that are potentially mediated via sex-related
expression differences of ERα. Future studies should
investigate how these findings have implications for
gender-based therapeutic strategies against
inflammation.
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